These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2564056)

  • 41. Immunoreactive dynorphin A-like material in extracted human hypothalamic-hypophysial plasma.
    Spampinato S; Paradisi R; Canossa M; Campana G; Frank G; Flamigni C; Ferri S
    Life Sci; 1993; 52(2):223-30. PubMed ID: 8102766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dynorphin immunoreactivity in pituitary.
    Cox BM; Baer ER; Goldstein A
    Adv Biochem Psychopharmacol; 1982; 33():43-50. PubMed ID: 6127005
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neurokinin A levels in the hypothalamus of rats and mice: effects of castration, gonadal steroids and expression of heterologous growth hormone genes.
    Debeljuk L; Ghosh P; Bartke A
    Brain Res Bull; 1990 Nov; 25(5):717-21. PubMed ID: 1963112
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley rats.
    Nylander I; Vlaskovska M; Terenius L
    Psychopharmacology (Berl); 1995 Apr; 118(4):391-400. PubMed ID: 7568625
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland.
    González S; Bisogno T; Wenger T; Manzanares J; Milone A; Berrendero F; Di Marzo V; Ramos JA; Fernández-Ruiz JJ
    Biochem Biophys Res Commun; 2000 Apr; 270(1):260-6. PubMed ID: 10733937
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Levels of dynorphin-(1-13) immunoreactivity in rat neurointermediate pituitaries are concomitantly altered with those of leucine enkephalin and vasopressin in response to various endocrine manipulations.
    Höllt V; Haarmann I; Seizinger BR; Herz A
    Neuroendocrinology; 1981 Dec; 33(6):333-9. PubMed ID: 6275285
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endogenous opioids, circadian rhythms, nutrient deprivation, eating and drinking.
    Reid LD; Konecka AM; Przewłocki R; Millan MH; Millan MJ; Herz A
    Life Sci; 1982 Oct 18-25; 31(16-17):1829-32. PubMed ID: 6130450
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Existence of different forms of adrenocorticotropin in rat hypothalamus.
    Argiolas A; Melis MR; Fratta W; Gessa GL
    Peptides; 1986; 7(4):591-6. PubMed ID: 3020525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deprivation of REM sleep in the rat and the opioid peptides beta-endorphin and dynorphin.
    Przewłocka B; Mogilnicka E; Lasón W; van Luijtelaar EL; Coenen AM
    Neurosci Lett; 1986 Sep; 70(1):138-42. PubMed ID: 2877419
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new opioid octapeptide related to dynorphin from porcine hypothalamus.
    Minamino N; Kangawa K; Fukuda A; Matsuo H; Iagarashi M
    Biochem Biophys Res Commun; 1980 Aug; 95(4):1475-81. PubMed ID: 7191256
    [No Abstract]   [Full Text] [Related]  

  • 51. Distribution of immunoreactive dynorphin A1-8 in discrete nuclei of the rat brain: comparison with dynorphin A.
    Zamir N; Palkovits M; Brownstein MJ
    Brain Res; 1984 Jul; 307(1-2):61-8. PubMed ID: 6147178
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of gonadal steroids on the content of substance P in the rat anterior pituitary.
    Coslovsky R; Evans RW; Leeman SE; Braverman LE; Aronin N
    Endocrinology; 1984 Dec; 115(6):2285-9. PubMed ID: 6209122
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Corelease of dynorphin-like immunoreactivity, luteinizing hormone, and follicle-stimulating hormone from rat adenohypophysis in vitro.
    Knepel W; Schwaninger M; Döhler KD
    Endocrinology; 1985 Aug; 117(2):481-7. PubMed ID: 2862008
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of dynorphin-A depletion in the anorexia of Walker-256 tumor bearing rats.
    Yim GK; Bryant HU; Malven PV
    Physiol Behav; 1985 Jul; 35(1):117-20. PubMed ID: 2865763
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple forms of immunoreactive dynorphin in human pituitary and pheochromocytoma.
    Suda T; Tozawa F; Tachibana S; Demura H; Shizume K; Sasaki A; Mouri T; Miura Y
    Life Sci; 1983 Feb; 32(8):865-70. PubMed ID: 6131371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Measurement and chromatographic characterization of prodynorphin-derived peptides in the guinea-pig ileum.
    Steele PA; Turner CA; Murphy R
    Neuropeptides; 1989 Apr; 13(3):207-13. PubMed ID: 2565558
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thyrotropin-releasing hormone in rat pituitary stalk blood and hypothalamus: studies with high performance liquid chromatography.
    Sheward WJ; Harmar AJ; Fraser HM; Fink G
    Endocrinology; 1983 Nov; 113(5):1865-9. PubMed ID: 6414807
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Opioid peptides of the pituitary and hypothalamus: changes in pregnant and lactating rats.
    Petraglia F; Baraldi M; Giarrè G; Facchinetti F; Santi M; Volpe A; Genazzani AR
    J Endocrinol; 1985 May; 105(2):239-45. PubMed ID: 3157762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Levels of immunoreactive dynorphin A1-13 during development of morphine dependence in rats.
    Wan XW; Li WH; Huang M; You ZD; Tan YX; Lu CL; Gong ZH
    Zhongguo Yao Li Xue Bao; 1998 Nov; 19(6):560-3. PubMed ID: 10437147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic prolactin, gonadal and thyroid hormone treatments in vivo alter levels of TRH and muscarinic receptors in male and female rat tissues.
    Sharif NA
    Brain Res; 1988 May; 449(1-2):364-8. PubMed ID: 2840173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.